Hereditary spastic paraplegia
ICD-10 G11.4 is a billable code used to indicate a diagnosis of hereditary spastic paraplegia.
Hereditary spastic paraplegia (HSP) is a group of inherited disorders characterized by progressive weakness and stiffness of the legs due to degeneration of the corticospinal tracts. The condition is caused by genetic mutations that affect the axonal transport and neuronal function, leading to the degeneration of upper motor neurons. Patients typically present with symptoms such as gait abnormalities, spasticity, and muscle weakness, which can vary in severity and onset. HSP can be classified into pure forms, where only spasticity is present, and complicated forms, which may include additional neurological symptoms such as ataxia, cognitive impairment, or seizures. The inheritance patterns can be autosomal dominant, autosomal recessive, or X-linked, with over 80 different genetic loci identified. Diagnosis is primarily clinical, supported by genetic testing to confirm specific mutations. Management focuses on symptomatic relief and rehabilitation to improve mobility and quality of life.
Detailed neurological examination findings, genetic testing results, and symptom progression.
Patients presenting with gait disturbances, spasticity, and family history of similar symptoms.
Ensure clear documentation of the type of hereditary spastic paraplegia and any associated neurological deficits.
Genetic test results, family history, and inheritance patterns.
Patients undergoing genetic counseling or testing for hereditary spastic paraplegia.
Accurate documentation of genetic mutations and their implications for family members.
Used for assessing cognitive function in patients with hereditary spastic paraplegia.
Detailed report of cognitive assessments and their implications.
Neurologists should ensure that cognitive assessments are linked to the diagnosis.
Hereditary spastic paraplegia is a genetic disorder characterized by progressive weakness and stiffness in the legs due to degeneration of upper motor neurons.
Diagnosis is primarily clinical, supported by genetic testing to confirm specific mutations associated with the condition.
